Table of Contents

Select this article
- X D Yang,
- S A Michie,
- R E Mebius,
- R Tisch,
- I Weissman,
- and H O McDevitt
The role of cell adhesion molecules in the development of IDDM: implications for pathogenesis and therapy.
Diabetes June 1996 45:705-710; doi:10.2337/diabetes.45.6.705
- Abstract
Select this article
- M C Harbeck,
- D C Louie,
- J Howland,
- B A Wolf,
- and P L Rothenberg
Expression of insulin receptor mRNA and insulin receptor substrate 1 in pancreatic islet beta-cells.
Diabetes June 1996 45:711-717; doi:10.2337/diabetes.45.6.711
- Abstract
Select this article
- K F Milde,
- M Alonso,
- S S Kong,
- R Alejandro,
- D H Mintz,
- and R L Pastori
Expression of a specific subset of CD44 variant transcripts in NOD pancreatic islets.
Diabetes June 1996 45:718-724; doi:10.2337/diabetes.45.6.718
- Abstract
Select this article
- L H Hansen,
- N Abrahamsen,
- J Hager,
- L Jelinek,
- W Kindsvogel,
- P Froguel,
- and E Nishimura
The Gly40Ser mutation in the human glucagon receptor gene associated with NIDDM results in a receptor with reduced sensitivity to glucagon.
Diabetes June 1996 45:725-730; doi:10.2337/diabetes.45.6.725
- Abstract
Select this article
- F Ishibashi
Microalbuminuria in NIDDM is caused by increased excretion of unmodified albumin.
Diabetes June 1996 45:731-735; doi:10.2337/diabetes.45.6.731
- Abstract
Select this article
- R J Katz,
- R E Ratner,
- R M Cohen,
- E Eisenhower,
- and D Verme
Are insulin and proinsulin independent risk markers for premature coronary artery disease ?
Diabetes June 1996 45:736-741; doi:10.2337/diabetes.45.6.736
- Abstract
Select this article
- S M Haffner,
- R D'Agostino,
- M F Saad,
- M Rewers,
- L Mykkänen,
- J Selby,
- G Howard,
- P J Savage,
- R F Hamman,
- and L E Wagenknecht
Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study.
Diabetes June 1996 45:742-748; doi:10.2337/diabetes.45.6.742
- Abstract
Select this article
- A Rabinovitch,
- W Suarez-Pinzon,
- A El-Sheikh,
- O Sorensen,
- and R F Power
Cytokine gene expression in pancreatic islet-infiltrating leukocytes of BB rats: expression of Th1 cytokines correlates with beta-cell destructive insulitis and IDDM.
Diabetes June 1996 45:749-754; doi:10.2337/diabetes.45.6.749
- Abstract
Select this article
- T E Stranberg,
- V Salomaa,
- H Vanhanen,
- and T A Miettinen
Associations of fasting blood glucose with cholesterol absorption and synthesis in nondiabetic middle-aged men.
Diabetes June 1996 45:755-761; doi:10.2337/diabetes.45.6.755
- Abstract
Select this article
- A J Jenkins,
- R L Klein,
- C N Chassereau,
- K L Hermayer,
- and M F Lopes-Virella
LDL from patients with well-controlled IDDM is not more susceptible to in vitro oxidation.
Diabetes June 1996 45:762-767; doi:10.2337/diabetes.45.6.762
- Abstract
Select this article
- M Trovati,
- P Massucco,
- L Mattiello,
- V Piretto,
- F Cavalot,
- E Mularoni,
- and G Anfossi
The insulin-induced increase of guanosine-3',5'-cyclic monophosphate in human platelets is mediated by nitric oxide.
Diabetes June 1996 45:768-770; doi:10.2337/diabetes.45.6.768
- Abstract
Select this article
- J I Reimers,
- H U Andersen,
- D Mauricio,
- F Pociot,
- A E Karlsen,
- J S Petersen,
- T Mandrup-Poulsen,
- and J Nerup
Strain-dependent differences in sensitivity of rat beta-cells to interleukin 1 beta in vitro and in vivo: association with islet nitric oxide synthesis.
Diabetes June 1996 45:771-778; doi:10.2337/diabetes.45.6.771
- Abstract
Select this article
- M Vives-Pi,
- M P Armengol,
- L Alcalde,
- M Costa,
- N Somoza,
- F Vargas,
- D Jaraquemada,
- and R Pujol-Borrell
Expression of transporter associated with antigen processing-1 in the endocrine cells of human pancreatic islets: effect of cytokines and evidence of hyperexpression in IDDM.
Diabetes June 1996 45:779-788; doi:10.2337/diabetes.45.6.779
- Abstract
Select this article
- H Inoue,
- A C Riggs,
- Y Tanizawa,
- K Ueda,
- A Kuwano,
- L Liu,
- H Donis-Keller,
- and M A Permutt
Isolation, characterization, and chromosomal mapping of the human insulin promoter factor 1 (IPF-1) gene.
Diabetes June 1996 45:789-794; doi:10.2337/diabetes.45.6.789
- Abstract
Select this article
- I Durinovic-Bellò,
- M Hummel,
- and A G Ziegler
Cellular immune response to diverse islet cell antigens in IDDM.
Diabetes June 1996 45:795-800; doi:10.2337/diabetes.45.6.795
- Abstract
Select this article
- O Schnell,
- D Muhr,
- M Weiss,
- S Dresel,
- M Haslbeck,
- and E Standl
Reduced myocardial 123I-metaiodobenzylguanidine uptake in newly diagnosed IDDM patients.
Diabetes June 1996 45:801-805; doi:10.2337/diabetes.45.6.801
- Abstract
Select this article
- T Kaumi,
- T Hirano,
- H Odaka,
- T Ebara,
- N Amano,
- T Hozumi,
- Y Ishida,
- and G Yoshino
VLDL triglyceride kinetics in Wistar fatty rats, an animal model of NIDDM: effects of dietary fructose alone or in combination with pioglitazone.
Diabetes June 1996 45:806-811; doi:10.2337/diabetes.45.6.806
- Abstract
Select this article
- B Hultgren,
- X Huang,
- N Dybdal,
- and T A Stewart
Genetic absence of gamma-interferon delays but does not prevent diabetes in NOD mice.
Diabetes June 1996 45:812-817; doi:10.2337/diabetes.45.6.812
- Abstract
Select this article
- V Bonnevie-Nielsen,
- K Buschard,
- and T Dyrberg
Differential responsiveness to interferon-alpha in beta-cells and non-beta cells.
Diabetes June 1996 45:818-821; doi:10.2337/diabetes.45.6.818
- Abstract
Select this article
- S M Haffner,
- M P Stern,
- H Miettinen,
- M Wei,
- and R L Gingerich
Leptin concentrations in diabetic and nondiabetic Mexican-Americans.
Diabetes June 1996 45:822-824; doi:10.2337/diabetes.45.6.822
- Abstract
Select this article
- H Inoue,
- J Ferrer,
- C M Welling,
- S C Elbein,
- M Hoffman,
- R Mayorga,
- M Warren-Perry,
- Y Zhang,
- H Millns,
- R Turner,
- M Province,
- J Bryan,
- M A Permutt,
- and L Aguilar-Bryan
Sequence variants in the sulfonylurea receptor (SUR) gene are associated with NIDDM in Caucasians.
Diabetes June 1996 45:825-831; doi:10.2337/diabetes.45.6.825
- Abstract
Select this article
- C Orskov,
- S S Poulsen,
- M Møller,
- and J J Holst
Glucagon-like peptide I receptors in the subfornical organ and the area postrema are accessible to circulating glucagon-like peptide I.
Diabetes June 1996 45:832-835; doi:10.2337/diabetes.45.6.832
- Abstract

Diabetes

The role of cell adhesion molecules in the development of IDDM: implications for pathogenesis and therapy.

Expression of insulin receptor mRNA and insulin receptor substrate 1 in pancreatic islet beta-cells.

Expression of a specific subset of CD44 variant transcripts in NOD pancreatic islets.

The Gly40Ser mutation in the human glucagon receptor gene associated with NIDDM results in a receptor with reduced sensitivity to glucagon.

Microalbuminuria in NIDDM is caused by increased excretion of unmodified albumin.

Are insulin and proinsulin independent risk markers for premature coronary artery disease ?

Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study.

Cytokine gene expression in pancreatic islet-infiltrating leukocytes of BB rats: expression of Th1 cytokines correlates with beta-cell destructive insulitis and IDDM.

Associations of fasting blood glucose with cholesterol absorption and synthesis in nondiabetic middle-aged men.

LDL from patients with well-controlled IDDM is not more susceptible to in vitro oxidation.

The insulin-induced increase of guanosine-3',5'-cyclic monophosphate in human platelets is mediated by nitric oxide.

Strain-dependent differences in sensitivity of rat beta-cells to interleukin 1 beta in vitro and in vivo: association with islet nitric oxide synthesis.

Expression of transporter associated with antigen processing-1 in the endocrine cells of human pancreatic islets: effect of cytokines and evidence of hyperexpression in IDDM.

Isolation, characterization, and chromosomal mapping of the human insulin promoter factor 1 (IPF-1) gene.

Cellular immune response to diverse islet cell antigens in IDDM.

Reduced myocardial 123I-metaiodobenzylguanidine uptake in newly diagnosed IDDM patients.

VLDL triglyceride kinetics in Wistar fatty rats, an animal model of NIDDM: effects of dietary fructose alone or in combination with pioglitazone.

Genetic absence of gamma-interferon delays but does not prevent diabetes in NOD mice.

Differential responsiveness to interferon-alpha in beta-cells and non-beta cells.

Leptin concentrations in diabetic and nondiabetic Mexican-Americans.

Sequence variants in the sulfonylurea receptor (SUR) gene are associated with NIDDM in Caucasians.

Glucagon-like peptide I receptors in the subfornical organ and the area postrema are accessible to circulating glucagon-like peptide I.

This Issue

Current Issue